Allink Biotherapeutics
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- $89M
Investors
- 10
About Allink Biotherapeutics
Established in 2023 and based in Shanghai, China, Allink Biotherapeutics operates as a biopharmaceutical company that focuses on the research and development of innovative drugs. The founder and CEO of the company, Hui Feng graduated from the Albert Einstein College of Medicine of Yeshiva University. The company mainly provides innovative drugs. Its core pipeline is ALK201 and ALK202, which are mainly used in the field of tumour treatment. Allink Biotherapeutics has also developed a bispecific antibody product pipeline and antibody-drug conjugates (ADCs). Bispecific antibodies are mainly targeted at tumours and immune diseases.
Who invested in Allink Biotherapeutics
10 investors across 2 rounds
See all investors in Allink Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Allink Biotherapeutics
Who invested in Allink Biotherapeutics?
Allink Biotherapeutics has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Allink Biotherapeutics raised?
Allink Biotherapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Allink Biotherapeutics last raise money?
Allink Biotherapeutics's most recent round on record is a Series A, in Dec 2025.
What does Allink Biotherapeutics do?
Established in 2023 and based in Shanghai, China, Allink Biotherapeutics operates as a biopharmaceutical company that focuses on the research and development of innovative drugs.
Where is Allink Biotherapeutics headquartered?
Allink Biotherapeutics is headquartered in Shanghai, China.
Which VCs invest in companies like Allink Biotherapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Allink Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Allink Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.